189 related articles for article (PubMed ID: 940284)
1. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Schroeder ET; Anderson GH; Goldman SH; Streeten DH
Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
[TBL] [Abstract][Full Text] [Related]
3. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II blockade in the canine puppy under different salt-intake.
Fiselier TJ; Monnens LA; Lameire NH; van Munster PJ; Peer PG; Leusen IR; Lijnen PJ
Kidney Int; 1984 Dec; 26(6):823-9. PubMed ID: 6398382
[TBL] [Abstract][Full Text] [Related]
5. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
Anderson GH; Streeten DH; Dalakos TG
Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
[TBL] [Abstract][Full Text] [Related]
6. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
7. Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
Saito I; Saruta T; Eguchi T; Nakamura R; Kondo K; Iyori S; Kato E
Jpn Heart J; 1978 Sep; 19(5):741-7. PubMed ID: 731936
[TBL] [Abstract][Full Text] [Related]
8. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
[TBL] [Abstract][Full Text] [Related]
11. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.
Hata T; Ogihara T; Mikami H; Nakamaru M; Mandai T; Kumahara Y
Eur J Clin Pharmacol; 1980 Oct; 18(4):295-9. PubMed ID: 7002566
[TBL] [Abstract][Full Text] [Related]
12. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog.
Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W
Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593
[TBL] [Abstract][Full Text] [Related]
15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II blockade by saralasin in normal man.
Noth RH; Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
[TBL] [Abstract][Full Text] [Related]
18. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
Beyer J; Liebau G; Steiner B; Hayduk K
Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system of the normothermic marmot.
Kastner PR; Zatzman ML; South FE; Johnson JA
Am J Physiol; 1977 Jul; 233(1):R37-43. PubMed ID: 195479
[TBL] [Abstract][Full Text] [Related]
20. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
